Clinical Utility of Quantitative HBV Core Antibodies for Solving Diagnostic Dilemmas.

Viruses · 2023 · PMC9965363 · PMID 36851587

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may be significantno p-value reported

These findings may be significant because the qAnti-HBc level can assist in recognising at-risk patients in the early stages of CHB, as these mutations are linked with faster progression of liver injury and risk of HCC development [ 73 ].

also in 13,097 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.